How protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian case

<p>Abstract</p> <p>Background</p> <p>Cervical cancer is one of the top causes of cancer morbidity and mortality in Colombia despite the existence of a national preventive program. Screening coverage with cervical cytology does not explain the lack of success of the prog...

Full description

Bibliographic Details
Main Authors: De la Hoz-Restrepo Fernando, Alvis-Guzman Nelson, Chocontá-Piraquive Luz
Format: Article
Language:English
Published: BMC 2010-09-01
Series:BMC Health Services Research
Online Access:http://www.biomedcentral.com/1472-6963/10/270
id doaj-4403cad432a04d62af5d03a525969c93
record_format Article
spelling doaj-4403cad432a04d62af5d03a525969c932020-11-24T20:54:14ZengBMCBMC Health Services Research1472-69632010-09-0110127010.1186/1472-6963-10-270How protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian caseDe la Hoz-Restrepo FernandoAlvis-Guzman NelsonChocontá-Piraquive Luz<p>Abstract</p> <p>Background</p> <p>Cervical cancer is one of the top causes of cancer morbidity and mortality in Colombia despite the existence of a national preventive program. Screening coverage with cervical cytology does not explain the lack of success of the program in reducing incidence and mortality rates by cervical cancer. To address this problem an ecological analysis, at department level, was carried out in Colombia to assess the relationship between cervical screening characteristics and cervical cancer mortality rates.</p> <p>Methods</p> <p>Mortality rates by cervical cancer were estimated at the department level for the period 2000-2005. Levels of mortality rates were compared to cervical screening coverage and other characteristics of the program. A Poisson regression was used to estimate the effect of different dimensions of program performance on mortality by cervical cancer.</p> <p>Results</p> <p>Screening coverage ranged from 28.7% to 65.6% by department but increases on this variable were not related to decreases in mortality rates. A significant reduction in mortality was found in departments where a higher proportion of women looked for medical advice when abnormal findings were reported in Pap smears. Geographic areas where a higher proportion of women lack health insurance had higher rates of mortality by cervical cancer.</p> <p>Conclusions</p> <p>These results suggest that coverage is not adequate to prevent mortality due to cervical cancer if women with abnormal results are not provided with adequate follow up and treatment. The role of different dimensions of health care such as insurance coverage, quality of care, and barriers for accessing health care needs to be evaluated and addressed in future studies.</p> http://www.biomedcentral.com/1472-6963/10/270
collection DOAJ
language English
format Article
sources DOAJ
author De la Hoz-Restrepo Fernando
Alvis-Guzman Nelson
Chocontá-Piraquive Luz
spellingShingle De la Hoz-Restrepo Fernando
Alvis-Guzman Nelson
Chocontá-Piraquive Luz
How protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian case
BMC Health Services Research
author_facet De la Hoz-Restrepo Fernando
Alvis-Guzman Nelson
Chocontá-Piraquive Luz
author_sort De la Hoz-Restrepo Fernando
title How protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian case
title_short How protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian case
title_full How protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian case
title_fullStr How protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian case
title_full_unstemmed How protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian case
title_sort how protective is cervical cancer screening against cervical cancer mortality in developing countries? the colombian case
publisher BMC
series BMC Health Services Research
issn 1472-6963
publishDate 2010-09-01
description <p>Abstract</p> <p>Background</p> <p>Cervical cancer is one of the top causes of cancer morbidity and mortality in Colombia despite the existence of a national preventive program. Screening coverage with cervical cytology does not explain the lack of success of the program in reducing incidence and mortality rates by cervical cancer. To address this problem an ecological analysis, at department level, was carried out in Colombia to assess the relationship between cervical screening characteristics and cervical cancer mortality rates.</p> <p>Methods</p> <p>Mortality rates by cervical cancer were estimated at the department level for the period 2000-2005. Levels of mortality rates were compared to cervical screening coverage and other characteristics of the program. A Poisson regression was used to estimate the effect of different dimensions of program performance on mortality by cervical cancer.</p> <p>Results</p> <p>Screening coverage ranged from 28.7% to 65.6% by department but increases on this variable were not related to decreases in mortality rates. A significant reduction in mortality was found in departments where a higher proportion of women looked for medical advice when abnormal findings were reported in Pap smears. Geographic areas where a higher proportion of women lack health insurance had higher rates of mortality by cervical cancer.</p> <p>Conclusions</p> <p>These results suggest that coverage is not adequate to prevent mortality due to cervical cancer if women with abnormal results are not provided with adequate follow up and treatment. The role of different dimensions of health care such as insurance coverage, quality of care, and barriers for accessing health care needs to be evaluated and addressed in future studies.</p>
url http://www.biomedcentral.com/1472-6963/10/270
work_keys_str_mv AT delahozrestrepofernando howprotectiveiscervicalcancerscreeningagainstcervicalcancermortalityindevelopingcountriesthecolombiancase
AT alvisguzmannelson howprotectiveiscervicalcancerscreeningagainstcervicalcancermortalityindevelopingcountriesthecolombiancase
AT chocontapiraquiveluz howprotectiveiscervicalcancerscreeningagainstcervicalcancermortalityindevelopingcountriesthecolombiancase
_version_ 1716795191985176576